0.343
price up icon1.51%   0.0051
 
loading
Precedente Chiudi:
$0.3379
Aprire:
$0.3357
Volume 24 ore:
676.58K
Relative Volume:
1.36
Capitalizzazione di mercato:
$28.50M
Reddito:
-
Utile/perdita netta:
$-126.61M
Rapporto P/E:
-0.175
EPS:
-1.96
Flusso di cassa netto:
$-60.14M
1 W Prestazione:
-3.41%
1M Prestazione:
-13.99%
6M Prestazione:
-70.17%
1 anno Prestazione:
-85.94%
Intervallo 1D:
Value
$0.3302
$0.3574
Intervallo di 1 settimana:
Value
$0.3004
$0.37
Portata 52W:
Value
$0.3004
$3.65

Generation Bio Co Stock (GBIO) Company Profile

Name
Nome
Generation Bio Co
Name
Telefono
857-529-5908
Name
Indirizzo
301 BINNEY STREET, CAMBRIDGE
Name
Dipendente
115
Name
Cinguettio
@generationbio
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
GBIO's Discussions on Twitter

Confronta GBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GBIO
Generation Bio Co
0.343 28.50M 0 -126.61M -60.14M -1.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Generation Bio Co Stock (GBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-10-19 Downgrade TD Cowen Outperform → Market Perform
2022-11-08 Iniziato Canaccord Genuity Buy
2021-12-14 Downgrade William Blair Outperform → Mkt Perform
2021-06-08 Iniziato JMP Securities Mkt Outperform
2021-02-24 Iniziato William Blair Outperform
2021-02-18 Iniziato Needham Buy
2020-07-07 Iniziato Cowen Outperform
2020-07-07 Iniziato JP Morgan Overweight
2020-07-07 Iniziato Jefferies Buy
2020-07-07 Iniziato Wedbush Outperform
Mostra tutto

Generation Bio Co Borsa (GBIO) Ultime notizie

pulisher
Jun 17, 2025

Post Bio announced on the 17th that it held a kick-off event for the open innovation project and sig.. - 매일경제

Jun 17, 2025
pulisher
Jun 16, 2025

64x Bio Launches AAV Apex Suite to Power the Next Generation of Gene Therapy Manufacturing - Business Wire

Jun 16, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Makes New $97,000 Investment in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 29,496 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Takes Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

What Did We Note About Insider Trading At Generation Bio Co (NASDAQ: GBIO)? - Stocksregister

Jun 09, 2025
pulisher
Jun 05, 2025

Generation Bio Elects Directors and Approves Key Proposals - TipRanks

Jun 05, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Buys 160,822 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace

Jun 02, 2025
pulisher
May 28, 2025

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference | GBIO Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 28, 2025
pulisher
May 28, 2025

Generation Bio Reveals Latest T Cell Therapy Progress: CEO Set for Major Jefferies Healthcare Conference Spotlight - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Generation Bio’s SWOT analysis: t-cell targeting tech reshapes stock outlook By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Has $366,000 Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

May 27, 2025
pulisher
May 27, 2025

Generation Bio’s SWOT analysis: t-cell targeting tech reshapes stock outlook - Investing.com Nigeria

May 27, 2025
pulisher
May 19, 2025

Pharma giant Eli Lilly eyes Houston for $5.9B biomanufacturing plant that could bring over 2,000 jobs - Houston Chronicle

May 19, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Has $420,000 Stock Holdings in Generation Bio Co. (NASDAQ:GBIO) - Defense World

May 17, 2025
pulisher
May 12, 2025

Wedbush Issues Negative Forecast for Generation Bio Earnings - Defense World

May 12, 2025
pulisher
May 10, 2025

Needham & Company LLC Reaffirms “Buy” Rating for Generation Bio (NASDAQ:GBIO) - Defense World

May 10, 2025
pulisher
May 09, 2025

Generation Bio Co (GBIO)’s Market Momentum: Closing Strong at 0.48, Down -6.25 - DWinneX

May 09, 2025
pulisher
May 09, 2025

Generation Bio Co. Reports Reduced Losses and Increased Revenue - TipRanks

May 09, 2025
pulisher
May 08, 2025

Where Generation Bio Stands With Analysts - Benzinga

May 08, 2025
pulisher
May 08, 2025

Needham Reiterates Buy Rating for Generation Bio (GBIO) | GBIO Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results - The Manila Times

May 08, 2025
pulisher
May 07, 2025

Generation Bio earnings beat by $0.08, revenue topped estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Metric Deep Dive: Understanding Generation Bio Co (GBIO) Through its Ratios - DWinneX

May 07, 2025
pulisher
May 05, 2025

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - ADVFN

May 05, 2025
pulisher
May 02, 2025

Stately Bio Raises $12M Seed to Develop Next Generation Regenerative Medicines with ML-Powered Cellular Imaging Platform - WebWire

May 02, 2025
pulisher
May 01, 2025

Renaissance Technologies LLC Has $1.02 Million Stock Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

May 01, 2025
pulisher
Apr 29, 2025

Revolutionary Green Innovation: Braskem's Bio-Based Polyethylene Transforms Nonwovens Industry - Stock Titan

Apr 29, 2025
pulisher
Apr 24, 2025

Generation Bio Co [GBIO] stock for 120,759 USD was acquired by Quinn Anthony G. - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

GBIO’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Generation Bio Co (GBIO) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 22, 2025

Generation Bio Insiders Recover Some Losses, Which Stand At US$115k - simplywall.st

Apr 22, 2025
pulisher
Apr 19, 2025

Generation Bio Co (NASDAQ: GBIO) Stock Is A Good Option To Consider - Stocksregister

Apr 19, 2025
pulisher
Apr 17, 2025

Next-Generation Biomanufacturing Market Current Scenario with Future Trends Analysis to 2031 - openPR.com

Apr 17, 2025
pulisher
Apr 12, 2025

Needham & Company LLC Reaffirms Buy Rating for Generation Bio (NASDAQ:GBIO) - Defense World

Apr 12, 2025
pulisher
Apr 08, 2025

GBIO stock plunges to 52-week low of $0.34 amid market challenges - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

GBIO stock plunges to 52-week low of $0.34 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 04, 2025

LG Innotek, KAIST collaborate for next gen technology - 매일경제

Apr 04, 2025
pulisher
Apr 03, 2025

Baker Hughes Co [BKR] Shares Rise 0.27 % on Wednesday - knoxdaily.com

Apr 03, 2025
pulisher
Apr 02, 2025

Generation Bio stock hits 52-week low at $0.4 amid steep decline - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - The Manila Times

Apr 02, 2025

Generation Bio Co Azioni (GBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Generation Bio Co Azioni (GBIO) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Quinn Anthony G.
Director
Jan 13 '25
Buy
0.97
85,000
82,450
299,286
Howze Yalonda
CHIEF LEGAL OFFICER
Oct 15 '24
Option Exercise
2.42
3,347
8,100
15,169
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):